Clinical trial · Interventional
EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors
Endoscopic Ultrasound-guided Fine-needle Injection for Nonfunctional Pancreatic Neuroendocrine Tumors: a Prospective Multicenter Study
NCT05566093CI-TRIAL-00061218unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The current study aims to access the feasibility, safety, and efficacy of EUS-FNI for nonfunctional pNETs
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endoscopic Ultrasound | — | UNRESOLVED | — |
| Nonfunctional Pancreatic Neuroendocrine Tumor | Non-Functioning Pancreatic Neuroendocrine Tumor | ALIAS | 0.90 |
| Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EUS-guided ethanol ablation | Procedure | — | UNRESOLVED |
| EUS-guided lauromacrogol ablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Nonfunctional pancreatic neuroendocrine tumors
- description
- The patients with NF-pNETs will undergo EUS-guided ethanol or lauromacrogol ablation
- interventionNames
- Procedure: EUS-guided ethanol ablation
- Procedure: EUS-guided lauromacrogol ablation
Primary outcomes (2)
- measure
- The rate of complete ablation
- timeFrame
- At 24 months after treatment
- description
- The rate of complete ablation on the CE-CT or CE-EUS
- measure
- The Chang The change of tumor size
- timeFrame
- From baseline to 24 months
- description
- The change of tumor size on the CE-CT or EUS
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with NF-pNETs are evaluated by cytology or immunohistochemistry. 2. Patients who refuse surgery or observation. 3. Patients who have given their fully informed consent. Exclusion Criteria: 1. Patients who are not suitable for EUS-FNI. 2. Patients who have poor conditions including blood coagulation dysfunction, mental disorders, and mild or severe cardiorespiratory.
References
Publications (0)
Data not yet available
No reference posted for this study.